Research Tracker›Biomarker Atlas›Marker Pages›SARS-CoV-2 RNA

SARS-CoV-2 RNA: biomarker evidence

SARS-CoV-2 RNA appears in 1 entry of the OSMF biomarker atlas, covering Long COVID. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Long COVID

Where SARS-CoV-2 RNA is reported

Also listed as: Viral RNAemia

ConditionDirectionCompared againstAssociated symptomsSource
Long COVID↕ inconsistenthealthy controlsViral reservoir hypothesisBaalbaki et al. 2025

Frequently asked questions

In which conditions is SARS-CoV-2 RNA altered?

In the OSMF atlas SARS-CoV-2 RNA is reported in Long COVID. It is mixed in 1 across 1 entries.

Is there a standard clinical test for SARS-CoV-2 RNA?

The atlas entries for SARS-CoV-2 RNA do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal SARS-CoV-2 RNA result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). SARS-CoV-2 RNA across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/sars-cov-2-rna.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.